The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer
Metrics: PDF 2481 views | HTML 2736 views | ?
Anna Chen1,2, Christina S.F. Wong3, Mira C.P. Liu1, Colin M. House1, Jaclyn Sceneay3, David D. Bowtell1,2,4,5, Erik W. Thompson6,7,8, Andreas Möller3
1Cancer Genomics and Genetics Laboratory, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne 3002, Australia
2Department of Pathology, The University of Melbourne, Parkville 3010, Australia
3Tumour Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston 4006, Australia
4Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville 3010, Australia
5Department of Biochemistry, The University of Melbourne, Parkville 3010, Australia
6The University of Melbourne Department of Surgery, St Vincent’s Hospital, Fitzroy 3065, Australia
7St Vincent’s Institute of Medical Research, Fitzroy 3065, Australia
8Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Queensland University of Technology, Kelvin Grove 4000, Australia
Andreas Möller, e-mail: firstname.lastname@example.org
Received: August 06, 2014 Accepted: November 04, 2014 Published: November 18, 2014
Elucidating the mechanisms that underlie metastasis is of paramount importance to understanding tumor progression and to the development of novel therapeutics. Epithelial to Mesenchymal Transition (EMT) plays a vital role in tumor cell dissemination and is regulated by a core cassette of transcription factors. Despite recent advances, the molecular pathways that regulate the EMT program have not yet been fully delineated. We show that Siah ubiquitin ligases regulate Zeb1 protein, a key EMT transcription factor. The induction of EMT in breast cancer cells leads to the down-regulation of Siah, while the loss of Siah induces a mesenchymal phenotype, concurrent with an up-regulation of Zeb1. Overexpression of Siah in vitro mediates Zeb1 degradation, which can be blocked with a Siah peptide inhibitor. Thus, this work demonstrates that Siah is a novel regulator of EMT. This work is the first to identify a mechanism of post-translational regulation of the key Epithelial to Mesenchymal Transition transcription factor Zeb1.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.